Peer-Reviewed Aging Research Journal
MISSION & AIMS
Cancer and aging are two sides of age-related tumorigenesis.
The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.
The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)
ARCHIVING & INDEXING
- PubMed/Medline (abbreviated as "Aging (Albany NY)")
- PubMed Central (abbreviated as "Aging (Albany NY)")
- Web of Science (abbreviated as "Aging-US") Update
- Scopus (abbreviated as "Aging")
- Biological Abstracts
- BIOSIS Previews
- EMBASE
- META (Chan Zuckerberg Initiative) (2018-2022). META database was discontinued in 2022.
- Dimensions (Digital Science)
In October 2024, Aging-US Journal received a letter from the Web of Science about the current discontinuation from the Core Collection. We believe that the decision should be reviewed and re-evaluated , and we are working with the Web of Science on the appeal. Aging journal is listed in the Master Journal List of the Web of Science, and covered in the BIOSIS Citation Index and Biological Abstracts under the categories of Cell Biology | Geriatrics & Gerontology.
Featured Nobel Articles
-
Elizabeth Blackburn, a member of the Editorial Board of Aging, won the Nobel Prize in Physiology or Medicine 2009, while being a member of the board. Elizabeth Blackburn co-authored a paper published in the first (inaugural) issue of Aging.
-
Andrew V. Schally, Nobel Prize Laureate, published his paper in Aging.
-
Shinya Yamanaka won the Nobel Prize in Physiology and Medicine 2012. Shinya Yamanaka co-authored a paper published in Aging.